Fumio Kokubu
- Immunology top 2%
- Immune Response and Inflammation 10
- Psoriasis: Treatment and Pathogenesis 8
- IL-33, ST2, and ILC Pathways 7
- Physiology top 5%
- Asthma and respiratory diseases 31
- Emergency Medical Services top 2%
- Dermatology top 2%
- Immunology and Allergy top 5%
-
- Cytokine Signaling Pathways and Interactions 10
- Chemokine receptors and signaling 6
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 7
- Respiratory and Cough-Related Research 7
- Co-authors
- Mitsuru AdachiSatoshi MatsukuraMio KawaguchiShau-Ku HuangNaruhito OdaKoushi IekiNobuyuki HizawaHisahiro Tokunaga
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Fumio Kokubu
68 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 116
- Immunology 1.3k
- Physiology 701
- Emergency Medical Services 171
- Dermatology 188
- Immunology and Allergy 126
Countries citing papers authored by Fumio Kokubu
This map shows the geographic impact of Fumio Kokubu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Kokubu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Kokubu more than expected).
Fields of papers citing papers by Fumio Kokubu
This network shows the impact of papers produced by Fumio Kokubu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Kokubu. The network helps show where Fumio Kokubu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fumio Kokubu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 16 | |
| 2 | 2015 | 14 | |
| 3 | 2014 | 67 | |
| 4 | 2013 | 26 | |
| 5 | 2012 | 131 | |
| 6 | 2010 | 14 | |
| 7 | 2009 | 44 | |
| 8 | [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate]. | 2007 | 2 |
| 9 | 2007 | 51 | |
| 10 | 2007 | 40 | |
| 11 | 2006 | 214 | |
| 12 | 2006 | 99 | |
| 13 | 2004 | 270 | |
| 14 | 2004 | 12 | |
| 15 | 2004 | 65 | |
| 16 | 2003 | 26 | |
| 17 | 2001 | 12 | |
| 18 | 1997 | 23 | |
| 19 | 1997 | 64 | |
| 20 | 1996 | 140 |
About Fumio Kokubu
Fumio Kokubu is a scholar working on Immunology, Physiology and Immunology and Allergy, having authored 69 papers that have together received 2.5k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (31 papers), Immune Response and Inflammation (10 papers), Cytokine Signaling Pathways and Interactions (10 papers), Psoriasis: Treatment and Pathogenesis (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Respiratory and Cough-Related Research (7 papers), IL-33, ST2, and ILC Pathways (7 papers) and Chemokine receptors and signaling (6 papers). The work is most often cited by research in Immunology (1.3k citations), Physiology (701 citations) and Emergency Medical Services (171 citations). Fumio Kokubu has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Mitsuru Adachi, Satoshi Matsukura, Mio Kawaguchi, Shau-Ku Huang, Naruhito Oda, Koushi Ieki, Nobuyuki Hizawa, Hisahiro Tokunaga, Miho Odaka and Shin Watanabe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.